Seroquel Class Action Lawsuit

Seroquel is a powerful antipsychotic drug. It is used to treat patients who have depressive disorders, including bi-polar and obsessive-compulsive disorders. The drug has been associated with various positive results, but it is often associated with serious side effects. Among these side effects include confusion, seizures, hypotension, changes in blood pressure, agitation, headache, constipation, nausea, sweating, dry mouth, and abdominal pain. Furthermore, many of the Seroquel class action lawsuit plaintiffs have serious neurological problems as a result of taking the drug.

Seroquel Class Action Lawsuit

In November 2009, the FDA warned that people using or taking seroquel may experience a rare but potentially deadly condition called Seroquel Extendar Syndrome. Seroquel XR is one of the major ingredients found in Neurontin-A, an FDA approved pharmaceutical treatment for high blood pressure. The FDA warned that taking Neurontin-A with seroquel could cause a serious increase in the risk of having an irregular heartbeat and abnormal heart rhythm, known as myocardial infarction (MI). This is especially serious because people with Seroquel class action lawsuit claims who have been taking the drug for months or even years may already have a heart condition. The FDA noted that it is very rare for anyone to die from this condition, but it can be life-threatening.

Neurontin-A itself has been linked to other side effects such as nervous tics, hallucinations, insomnia, dizziness, and depression.

The FDA did not find sufficient evidence to link Seroquel XR to heart attacks, but it has been linked to strokes and sudden death. The company had also previously been linked to abnormal behavior in children and adolescents. In addition to the Neurontin-A links, there are many other common side effects from taking the class action lawsuit. These include stomach problems, vision problems, urinary and bowel difficulties, fatigue, dizziness, allergic reactions, problems with vision and hearing, among others.

A major deficiency noted in Seroquel XR 300 mg Kullananlar is that there is no FDA-approved warnings about the use of this medication in pregnant women.

There are only minimal concerns expressed about the risks of Seroquel XR if you take the drug while breast feeding. It is possible to reduce the possibility of developing side effects by using the drug while breast feeding by taking an additional dose after the baby is born. The FDA has not approved Neurontin-A for use by children less than twelve years of age. Some studies do indicate that there might be some developmental problems related to the use of Seroquel, but the results of these studies have been disputed by the company.

The Seroquel class action lawsuit was brought by the parents of a young boy who died from severe allergic reactions to the Seroquel drug.

He had been diagnosed as having depressive symptoms. It was not known at that time that Neurontin (the drug) was causing heart problems. As the boy began to show signs of clinical depression, his parents became concerned and sought help from a professional. The FDA warned that there could be dangerous outcomes if the child continued to use Neurontin.

The FDA has also warned that there may be a link between Neurontin use and low sperm count in men.

While the exact results of the study have not been disclosed, it seems likely that taking two different drugs (neuroleptics) might result in lower sperm count and therefore, a reduced likelihood of conception.

The FDA has also warned that both neuroleptics Neurontin and Prazosanthe (antipsychotic used to treat anxiety disorders) can cause stomach ulcer, erosion of bone, constipation, nausea and vomiting, diarrhea, dry mouth and persistent dry lips. One of the worst side effects of Neurontin is its potential to cause sudden death. Nausea, dizziness, dry mouth and drowsiness are all signs of an imminent collapse. Because of these risks, the FDA has placed the Seroquel Class Action Lawsuit on the Preventing Drug Recurrence Watch List.

Leave a Reply

Your email address will not be published. Required fields are marked *